Cargando…
HSPA4 Is a Biomarker of Placenta Accreta and Enhances the Angiogenesis Ability of Vessel Endothelial Cells
Placenta accreta spectrum (PAS) accounts for 7% of maternal mortality and is associated with intraoperative and postoperative morbidity caused by massive blood loss, infection, and adjacent organ damage. The aims of this study were to identify the protein biomarkers of PAS and to further explore the...
Autores principales: | Li, Sung-Chou, Lan, Kuo-Chung, Hung, Hsuan-Ning, Huang, Wan-Ting, Lai, Yun-Ju, Cheng, Hsin-Hsin, Tsai, Chih-Chang, Huang, Kun-Long, You, Huey-Ling, Hsu, Te-Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143901/ https://www.ncbi.nlm.nih.gov/pubmed/35628491 http://dx.doi.org/10.3390/ijms23105682 |
Ejemplares similares
-
Effect of placenta location detected by ultrasound on the severity of placenta accreta spectrum in patients with placenta previa and placenta accreta spectrum
por: Liu, Hong, et al.
Publicado: (2023) -
Placenta accreta: adherent placenta due to Asherman syndrome
por: Engelbrechtsen, Line, et al.
Publicado: (2015) -
Magnetic resonance imaging of placenta accreta
por: Varghese, Binoj, et al.
Publicado: (2013) -
Retained Placenta Accreta Mimicking Choriocarcinoma
por: Kohi, Maureen P., et al.
Publicado: (2015) -
Placenta accreta following hysteroscopic myomectomy
por: Tanaka, Mie, et al.
Publicado: (2016)